SCHEMBL10880907

SCHEMBL10880907

CCc1cc(N(C)C(C)=O)cc(CC)c1N=C1NCCN1

nearest known ligand 0.32

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
SRD5A1 P18405 2/20 0.32
SMN1; SMN2 Q16637 2/20 0.31
POLB P06746 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10876477 0.81 FSCN1 (0.36) SMN1; SMN2
SCHEMBL10879477 0.81 SMN1; SMN2 (0.32) SMN1; SMN2
SCHEMBL10883141 0.77 PTPN1 (0.31)
SCHEMBL10878458 0.76 FSCN1 (0.33)
SCHEMBL10876630 0.75 LMNA (0.39) POLB
Hydrochloric Acid SCHEMBL10816153 0.74 LMNA (0.38) SMN1; SMN2POLB
SCHEMBL9616491 0.73 NOS3 (0.31)
Hydrochloric Acid SCHEMBL10879822 0.72 NOS3 (0.30)
SCHEMBL11033315 0.71 POLB (0.42) SMN1; SMN2POLB
SCHEMBL5154555 0.70 GABRA1 (0.46)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0081924-B1 TOPICAL COMPOSTIONS FOR LOWERING INTRAOCULAR PRESSURE ALCON LABORATORIES, INC. (US) 1986-02-19 EP disclosed
US-4517199-A TREATMENT OF GLAUCOMA ALCON LABORATORIES, INC. (US) 1985-05-14 US disclosed
US-4515800-A GLAUCOMA ALCON MANUFACTURING, LTD. 1985-05-07 US disclosed
EP-0081924-A1 Topical compostions for lowering intraocular pressure ALCON LABORATORIES, INC. (US) 1983-06-22 EP disclosed